Related Experiment Video
Updated: Jun 17, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
The shelf life of antimicrobial ear drops
Matthew P A Clark1, Lyela Pangilinan, Amy Wang
1Division of Otolaryngology, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
Objectives/Hypothesis:
The advice given to patients regarding the shelf life of antimicrobial ear drops is based on little or no evidence. We aimed to determine appropriate recommendations for the shelf life of common antibiotic-containing topical otic solutions.
Study Design:
Prospective experimental design.
Methods:
Ear drops containing gentamicin and ciprofloxacin were analyzed. Their effectiveness was assessed on agar plates inoculated with both Staphylococcus aureus and Pseudomonas aeruginosa. Bottles were also assessed for contamination once opened. In addition, drops used for 1 week on patients with culture-positive otorrhea were analyzed for contamination of both the bottle teat and the drop solution.
Results:
Neither antibiotic showed deterioration in effectiveness against either microorganism over a 4-month period, as assessed by the size of inhibitory zones on inoculated agar plates. Of drops returned after use on infected patients, none of the cultures from the teats of the bottle grew any organisms. The drop solution itself also showed no contamination after having been opened for 4 months and used by a patient.
Conclusions:
There appears to be no evidence that antimicrobial ear drops containing either gentamicin or ciprofloxacin lose their efficacy against either S. aureus or P. aeruginosa over at least 4 months from opening, or that the bottle contents become contaminated after use in patients with culture-positive otorrhea. It is likely these findings apply to other antimicrobial drops and for other organisms. This allows us to advise patients to keep unfinished drops for potential future use with beneficial economic implications.
Insights
Antimicrobial ear drops containing gentamicin or ciprofloxacin remain effective and uncontaminated for at least four months after opening. This supports advising patients to keep unfinished ear drops for future use, offering economic benefits.
Area of Science:
- Otolaryngology
- Microbiology
- Pharmacology
Background:
- Current recommendations for antimicrobial ear drop shelf life lack empirical evidence.
- Topical otic solutions are frequently prescribed for otorrhea.
Purpose of the Study:
- To determine appropriate shelf-life recommendations for antibiotic-containing ear drops.
- To assess the stability and sterility of common antimicrobial otic solutions.
Main Methods:
- Prospective experimental study design.
- Effectiveness testing of gentamicin and ciprofloxacin ear drops against Staphylococcus aureus and Pseudomonas aeruginosa using agar plates.
- Assessing bottle teat and drop solution contamination after patient use.
Main Results:
- No loss of antibiotic effectiveness observed over a 4-month period.
- No microbial contamination detected on bottle teats of drops used by patients with otorrhea.
- No contamination of ear drop solutions found after 4 months of use.
Conclusions:
- Antimicrobial ear drops with gentamicin or ciprofloxacin maintain efficacy and sterility for at least 4 months post-opening.
- Findings suggest extended usability for patients, potentially including other antimicrobial drops.
- Supports advising patients to retain unused ear drops for future therapeutic needs, enhancing cost-effectiveness.
Related Concept Videos
Drug Product Stability
Antimicrobial Effectiveness
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Ophthalmic Drug Delivery Systems
Pharmacokinetics in Pediatric Patients: Drug Excretion

